Research Network

Collaboration plays a vital role in scientific and academic endeavors, and it is an essential aspect of the work conducted at the Laboratory for Cancer, Immunity, and Inflammation. We firmly believe that collaboration is key to advancing knowledge, fostering innovation, and tackling complex research questions more effectively.  

Our laboratory actively seeks and engages in collaborations with a diverse network of researchers, scientists, clinicians, and institutions. By joining forces with experts from various disciplines and backgrounds, we can bring together complementary expertise, perspectives, and resources to address multifaceted challenges in cancer, immunity, and inflammation research.  

In our collaborations, we prioritize open communication, mutual respect, and shared goals. We cultivate an environment that promotes active dialogue, idea exchange, and constructive feedback. Through regular meetings, conferences, and workshops, we establish channels for effective communication and encourage ongoing collaboration and learning.  

Collaborations extend beyond geographical boundaries, and we actively seek partnerships on both national and international levels. We engage with researchers and institutions across the globe, forming networks that enhance our research capacity and expand our reach. These collaborations foster cross-cultural understanding, promote knowledge transfer, and facilitate the dissemination of scientific findings on a global scale.  

 


Translational Cancer Network

The Translational Cancer Network is chaired by Professor Martin R Jakobsen and Professor, MD, Signe Borgquist. The vision of the network is to help keep a consistent focus on translating newest findings from basic research into the clinical situation, and vice versa, to create new and better treatments for patients. 

The Faculty of Health has many talented cancer researchers who work within a variety of highly specialised areas, and  the network is our meeting forum.

The network has been initiated to help create an even more collaborative culture and provide greater insight into projects within the areas of translational cancer research at Aarhus University and Region Midt. We wish to maximise our knowledge sharing and turn Aarhus into a beacon within the translational area of cancer research.

Read more about TCN here https://health.au.dk/en/the-translational-cancer-network

The Translational Cancer Network


ACADEMIA COLLABORATIONS

Local

  • Associate Professor Rasmus Bak (pDC, CRISPR engineering)
  • Associate Professor Anders Etzerodt (cancer immunology and LNPs)
  • Associate Professor Nicolai Birkbak (cancer genetics)
  • Professor Lars Dyrskjøt Andersen (caner genetics)
  • Chair, Professor, MD Signe Borgquist (cancer, breast)
  • MD Anne Winther (cancer, lung)
  • MD Ninna Aggerholm-Pedersen (cancer, sarcoma)
  • MD Henrik Schmidt (cancer, melanoma)
  • MD Louise Guldbrandt (cancer, melanoma)
  • Associate Professor Lasse Sommer (cancer genetics)
  • Associate Professor David Olagnier (cancer and immunology)
  • Professor Søren R Paludan (immunology)
  • Professor, MD Ebbe Bødtker (cancer IHC)
  • Professor, MD, Bent Deleuran (immunology)
  • Professor Christian Holm (immunology)
  • Professor Thomas Poulsen (chemistry)
  • Professor Brita Singers Sørense (radiotherapy)
  • Professor Michael R Horsman (radiotherapy)

External

  • Professor Nadia Roan (Gladstone Institute, SF, USA / HIV and immunology)
  • Professor Andreas Lundquist (Karolinska Institute, SE / cancer)
  • Professor Emilie Voest (NKI, NE / cancer)
  • Associate Professor Emil Kofoed-Olesen (Aalborg University, DK / cancer)

LIFE-SCIENCE INTERACTIONS

Collaborations with industry partners enable us to bridge the gap between academic research and real-world applications. By working together with pharmaceutical companies, biotech firms, and technology developers, we can accelerate the translation of our research findings into tangible clinical benefits, diagnostic tools, therapies, and medical advancements. These collaborations ensure that our research has a direct impact on patient care and public health.

Professor Martin Jakobsen has been actively involved in national life-science innovation and entrepreneurship since 2017. He has been able to spin-out two biotech companies from Aarhus University in 2018 and 2020 that was based on scientific discoveries made in his academic lab. 

Today, the lab has collaborative activities with STipe Therapeutics; Unikum Therapeutics; BioXpedia and Samplix, and is always willing to meet with biotech/pharma to discuss new collaborations.

Interested in setting up collaborations?

Please contact Professor Martin R Jakobsen for more information